SK Biopharmaceuticals. (326030.KQ) Q2 2026 Earnings

7MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
349.08
802.9
1,256.71
1,710.53

Details

Expected EPS
464.6559689712
Actual EPS
1267.1636388023999
Surprise EPS
802.51
Surprise Percent
+172.71%

Description

SK Biopharmaceuticals. (326030.KQ) has reported earnings of 1267.1636388023999 per share for Q2 2026.

0 Comments

Share your thoughts